• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    68 Biggest Movers From Yesterday

    3/3/22 3:53:44 AM ET
    $ADV
    $AGEN
    $AKA
    $ANF
    Real Estate
    Real Estate
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ADV alert in real time by email

    Gainers

    • ECMOHO Limited (NASDAQ:MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday.
    • Imperial Petroleum Inc. (NASDAQ:IMPP) shares jumped 39.2% to close at $2.06 after dipping 37% on Tuesday.
    • Nordstrom, Inc. (NYSE:JWN) shares jumped 37.8% to settle at $26.93 after the company reported better-than-expected Q4 EPS and sales results. The company also issued FY22 guidance.
    • Regulus Therapeutics Inc. (NASDAQ:RGLS) gained 35.6% to close at $0.3050.
    • Indonesia Energy Corporation Limited (NASDAQ:INDO) surged 34.5% to close at $14.50.
    • Trevi Therapeutics, Inc. (NASDAQ:TRVI) gained 32% to settle at $1.15.
    • Arlo Technologies, Inc. (NYSE:ARLO) rose 28.9% to close at $11.19 after the company reported better-than-expected Q4 results. The company also issued Q1 sales guidance above analyst estimates.
    • Rocky Brands, Inc. (NASDAQ:RCKY) climbed 26.6% to close at $47.47 following better-than-expected Q4 results.
    • China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) gained 26.1% to close at $0.2181.
    • Universal Security Instruments, Inc. (NYSE:UUU) jumped 25.9% to close at $4.96.
    • Exicure, Inc. (NASDAQ:XCUR) jumped 25.7% to close at $0.2639 after gaining around 5% on Tuesday.
    • SemiLEDs Corporation (NASDAQ:LEDS) gained 25.3% to settle at $4.31.
    • Borr Drilling Limited (NYSE:BORR) shares jumped 24.4% to close at $2.65. Borr Drilling reported the retirement of Ms Georgina Sousa as a Director and Company Secretary.
    • Cerberus Cyber Sentinel Corporation (NASDAQ:CISO) gained 23.7% to settle at $4.91.
    • Organogenesis Holdings Inc. (NASDAQ:ORGO) shares gained 21.4% to close at $8.79 after the company reported Q4 EPS results up from last year and better-than-expected sales results.
    • Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) jumped 21.1% to close at $3.04 following Q4 results.
    • Hour Loop, Inc. (NASDAQ:HOUR) gained 20.5% to close at $2.70.
    • Molecular Data Inc. (NASDAQ:MKD) surged 20.5% to close at $0.1825.
    • Membership Collective Group Inc. (NYSE:MCG) jumped 20.2% to close at $9.11.
    • Agenus Inc. (NASDAQ:AGEN) climbed 18.5% to close at $3.07. HC Wainwright & Co. maintained Agenus with a Buy and raised the price target from $12 to $14.
    • Prudential Bancorp, Inc. (NASDAQ:PBIP) jumped 18.3% to close at $17.11. Fulton Financial Corporation and Prudential Bancorp, Inc. announced merger.
    • Ramaco Resources, Inc. (NASDAQ:METC) jumped 17.9% to close at $18.77. Ramaco Resources recently reported worse-than-expected Q4 sales results.
    • MannKind Corporation (NASDAQ:MNKD) gained 17.8% to settle at $3.24. MannKind recently gave an update on the Tyvaso DPI New Drug Application.
    • American Resources Corporation (NASDAQ:AREC) jumped 17.8% to close at $2.25.
    • XL Fleet Corp. (NYSE:XL) rose 17.4% to close at $2.16 after the company reported better-than-expected Q4 sales results.
    • Apollo Endosurgery, Inc. (NASDAQ:APEN) jumped 17.1% to settle at $7.19.
    • Ikena Oncology, Inc. (NASDAQ:IKNA) gained 16.8% to close at $7.00.
    • Ardelyx, Inc. (NASDAQ:ARDX) climbed 16.8% to close at $0.85. Jefferies upgraded Ardelyx from Hold to Buy and raised the price target from $1 to $5.
    • Harpoon Therapeutics, Inc. (NASDAQ:HARP) jumped 16.3% to close at $4.65. Harpoon Therapeutics received FDA fast track designation for HPN217, A BCMA-targeting TriTAC for the treatment of patients with relapsed, refractory multiple myeloma.
    • EPAM Systems, Inc. (NYSE:EPAM) climbed 16.1% to settle at $245.17.
    • BTRS Holdings Inc. (NASDAQ:BTRS) gained 16.1% to close at $6.50 after the company reported better-than-expected Q4 sales results and issued FY22 sales guidance above analyst estimates.
    • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) rose 15.9% to settle at $0.3511.
    • ENGlobal Corporation (NASDAQ:ENG) jumped 15.3% to close at $1.51.
    • BigBear.ai Holdings, Inc. (NYSE:BBAI) jumped 14.4% to settle at $6.68.
    • CytomX Therapeutics, Inc. (NASDAQ:CTMX) gained 14.1% to close at $4.04 following Q4 results.
    • Comstock Mining Inc. (NASDAQ:LODE) jumped 13.5% to close at $1.77.
    • PLBY Group, Inc. (NASDAQ:PLBY) rose 12.3% to close at $16.42 after the company reported better-than-expected Q4 sales results.
    • Cue Health Inc. (NASDAQ:HLTH) gained 11.8% to settle at $10.15.
    • ZipRecruiter, Inc. (NYSE:ZIP) gained 11.5% to close at $21.53 after the company reported better-than-expected Q4 sales results and reported a $100 million buyback.
    • Avenue Therapeutics, Inc. (NASDAQ:ATXI) rose 8.8% to close at $0.66 after jumping 78% on Tuesday. Avenue Therapeutics, last month, announced the outcome of the FDA meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee on IV tramadol.
    • Sasol Limited (NYSE:SSL) rose 8.6% to close at $25.31. Sasol announced the sale of its German subsidiary Sasol Wax GmbH to AWAX s.p.a.
    • Scientific Games Corporation (NASDAQ:SGMS) gained 7.6% to close at $62.06 after the company reported better-than-expected sales from continuing operations and a $750 million buyback.

     


    Losers

    • SAB Biotherapeutics, Inc. (NASDAQ:SABS) shares tumbled 39.9% to close at $2.76 on Wednesday. SAB Biotherapeutics said that due to low hospitalization and death rates in the trial, the National Institutes of Health's (NIH) ACTIV-2 Program is discontinuing enrollment in its Phase 3 COVID-19 trial.
    • Karyopharm Therapeutics Inc. (NASDAQ:KPTI) dropped 39.8% to close at $6.26 on Wednesday after the company announced it received feedback from the FDA that the current SIENDO study top-line results are unlikely to support an sNDA approval.
    • Puhui Wealth Investment Management Co., Ltd. (NASDAQ:PHCF) fell 36.1% to close at $0.8438.
    • GoHealth, Inc. (NASDAQ:GOCO) fell 33.2% to close at $1.33 after the company reported preliminary Q4 and year-end results. Truist Securities downgraded GoHealth from Buy to Hold.
    • a.k.a. Brands Holding Corp. (NYSE:AKA) fell 26.9% to settle at $5.11 after the company issued Q1 sales guidance below analyst estimates.
    • 1stdibs.Com, Inc. (NASDAQ:DIBS) dropped 22.6% to close at $8.00 after the company reported worse-than-expected Q4 EPS and sales results and issued Q1 sales guidance below estimates.
    • Meta Materials Inc. (NASDAQ:MMAT) dropped 20.7% to close at $1.65.
    • HOOKIPA Pharma Inc. (NASDAQ:HOOK) fell 20.6% to close at $2.00 after the company reported an offering of common shares and non-voting convertible preferred stock.
    • Array Technologies, Inc. (NASDAQ:ARRY) fell 20.1% to close at $9.36.
    • Bright Health Group, Inc. (NYSE:BHG) dropped 19.6% to close at $2.51 after the company reported worse-than-expected Q4 EPS and sales results.
    • CooTek (Cayman) Inc. (NYSE:CTK) fell 18.8% to close at $0.2601 after gaining over 36% on Tuesday.
    • ChemoCentryx, Inc. (NASDAQ:CCXI) shares fell 16.7% to close at $24.55 after the company reported worse-than-expected Q4 EPS and sales results.
    • Cepton, Inc. (NASDAQ:CPTN) fell 16.4% to settle at $9.40.
    • TeraWulf Inc. (NYSE:WULF) tumbled 16.2% to close at $9.29.
    • GreenLight Biosciences Holdings (NASDAQ:GRNA) fell 15.6% to close at $5.31.
    • Advantage Solutions Inc. (NASDAQ:ADV) dropped 14.1% to close at $6.62. Advantage Solutions said Jill Griffin will become CEO.
    • TPI Composites, Inc. (NASDAQ:TPIC) fell 14% to close at $12.07.
    • SciSparc Ltd. (NASDAQ:SPRC) declined 14% to settle at $3.57. SciSparc recently appointed Oz Adler as CEO.
    • Abercrombie & Fitch Co. (NYSE:ANF) dipped 13.1% to close at $31.16 after the company reported worse-than-expected Q4 EPS and sales results.
    • Finch Therapeutics Group, Inc. (NASDAQ:FNCH) fell 12.5% to settle at $7.35 after the company reported enrollment was paused in its PRISM4 Phase 3 trial for recurrent C. Difficile infection candidate.
    • NerdWallet, Inc. (NASDAQ:NRDS) dropped 12.4% to close at $9.55.
    • Motorsport Games Inc. (NASDAQ:MSGM) fell 12.3% to settle at $2.93.
    • Certara, Inc. (NASDAQ:CERT) fell 11.1% to close at $21.93 following Q4 results.
    • Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC) shares fell 8.4% to close at $8.12 after the company breached its US deferred prosecution agreement for a second time.
    • First Solar, Inc. (NASDAQ:FSLR) fell 8.1% to close at $69.51 after the company reported worse-than-expected Q4 sales results and issued FY22 guidance.
    • Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares fell 5.9% to close at $3.05 after the company reported downbeat Q4 results.

    Also check this out: Insiders Buy Around $2.8M Of 3 Stocks.

    Get the next $ADV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADV
    $AGEN
    $AKA
    $ANF

    CompanyDatePrice TargetRatingAnalyst
    Karyopharm Therapeutics Inc.
    $KPTI
    2/5/2026Overweight
    Cantor Fitzgerald
    First Solar Inc.
    $FSLR
    1/29/2026$263.00Outperform → Market Perform
    BMO Capital Markets
    Array Technologies Inc.
    $ARRY
    1/28/2026$11.00Outperform → Neutral
    Robert W. Baird
    Abercrombie & Fitch Company
    $ANF
    1/21/2026$135.00Neutral → Buy
    Citigroup
    CytomX Therapeutics Inc.
    $CTMX
    1/20/2026$10.00Buy
    Guggenheim
    Ramaco Resources Inc.
    $METC
    1/20/2026$30.00Hold → Buy
    Jefferies
    Sasol Ltd.
    $SSL
    1/16/2026Neutral → Underweight
    Analyst
    First Solar Inc.
    $FSLR
    1/13/2026Mkt Perform
    Raymond James
    More analyst ratings

    $ADV
    $AGEN
    $AKA
    $ANF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    GENERAL COUNSEL Busse Brian sold $587,486 worth of shares (47,329 units at $12.41) and was granted 57,410 shares, increasing direct ownership by 2% to 552,850 units (SEC Form 4)

    4 - Arlo Technologies, Inc. (0001736946) (Issuer)

    2/6/26 7:45:05 PM ET
    $ARLO
    Consumer Electronics/Appliances
    Consumer Staples

    CEO Mcrae Matthew Blake sold $2,136,923 worth of shares (172,015 units at $12.42) and was granted 167,447 shares, decreasing direct ownership by 0.45% to 1,011,288 units (SEC Form 4)

    4 - Arlo Technologies, Inc. (0001736946) (Issuer)

    2/6/26 7:44:14 PM ET
    $ARLO
    Consumer Electronics/Appliances
    Consumer Staples

    Chief Executive Officer Horowitz Fran sold $6,920,168 worth of shares (67,031 units at $103.24), decreasing direct ownership by 17% to 338,272 units (SEC Form 4)

    4 - ABERCROMBIE & FITCH CO /DE/ (0001018840) (Issuer)

    2/6/26 4:55:25 PM ET
    $ANF
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $ADV
    $AGEN
    $AKA
    $ANF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ault Milton C Iii bought $1,230,000 worth of shares (205,000 units at $6.00) (SEC Form 4)

    4 - UNIVERSAL SAFETY PRODUCTS, INC. (0000102109) (Issuer)

    2/6/26 4:30:08 PM ET
    $UUU
    Electronic Components
    Technology

    Director Ault Milton C Iii bought $570,000 worth of shares (95,000 units at $6.00) (SEC Form 4)

    4 - UNIVERSAL SAFETY PRODUCTS, INC. (0000102109) (Issuer)

    1/21/26 4:30:41 PM ET
    $UUU
    Electronic Components
    Technology

    Director Ault Milton C Iii bought $20,070 worth of shares (4,060 units at $4.94) (SEC Form 4)

    4 - UNIVERSAL SAFETY PRODUCTS, INC. (0000102109) (Issuer)

    1/2/26 6:04:20 AM ET
    $UUU
    Electronic Components
    Technology

    $ADV
    $AGEN
    $AKA
    $ANF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TeraWulf Schedules Conference Call for Fourth Quarter 2025 Financial Results

    EASTON, Md., Feb. 06, 2026 (GLOBE NEWSWIRE) -- TeraWulf Inc. (NASDAQ:WULF) ("TeraWulf" or the "Company"), a leading owner and operator of vertically integrated digital infrastructure, today announced that it will host its earnings conference call and webcast for the fourth quarter ended December 31, 2025 on Thursday, February 26, 2026 at 4:30 p.m. Eastern Time. A press release detailing the Company's financial results will be issued prior to the call on the same day. Conference Call Information To participate in this event, please log on or dial in approximately five minutes before the scheduled start time. Date: February 26, 2026Time: 4:30 p.m. ETAccess ID: 13758665Webcast: https://vi

    2/6/26 9:28:54 AM ET
    $WULF
    EDP Services
    Technology

    Abercrombie & Fitch Co. to Report Fourth Quarter and Full Year 2025 Results on March 4, 2026

    NEW ALBANY, Ohio, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Abercrombie & Fitch Co. (NYSE:ANF) will host its quarterly earnings conference call for all interested parties on Wednesday, March 4, 2026, at 8:30 a.m. ET. A press release detailing the company's fourth quarter and full year results is expected to be issued shortly after 7:30 a.m. ET. In addition, a presentation of the fourth quarter and full year results will be available on the company's website at approximately 7:30 a.m. ET. Conference Call:To access the conference call by phone, participants will need to register to obtain a dial-in phone number and an access code. Register for the call using this link.  Webcast:To listen to a live w

    2/6/26 8:00:00 AM ET
    $ANF
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Churchill Capital Corp XI Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 9, 2026

    New York, NY, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Churchill Capital Corp XI (NASDAQ:CCXIU) (the "Company") announced today that, commencing February 9, 2026, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq Global Market under the symbols "CCXI" and "CCXIW," respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol "CCXIU." This press re

    2/5/26 4:28:00 PM ET
    $CCXI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADV
    $AGEN
    $AKA
    $ANF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Karyopharm Therapeutics

    Cantor Fitzgerald initiated coverage of Karyopharm Therapeutics with a rating of Overweight

    2/5/26 6:58:02 AM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    First Solar downgraded by BMO Capital Markets with a new price target

    BMO Capital Markets downgraded First Solar from Outperform to Market Perform and set a new price target of $263.00

    1/29/26 7:00:08 AM ET
    $FSLR
    Semiconductors
    Technology

    Array Tech downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Array Tech from Outperform to Neutral and set a new price target of $11.00

    1/28/26 7:12:30 AM ET
    $ARRY
    Miscellaneous manufacturing industries
    Consumer Discretionary

    $ADV
    $AGEN
    $AKA
    $ANF
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated

    10/20/23 4:37:52 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:43:04 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZA™ issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZA™ (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:37:08 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADV
    $AGEN
    $AKA
    $ANF
    SEC Filings

    View All

    SEC Form 144 filed by Arlo Technologies Inc.

    144 - Arlo Technologies, Inc. (0001736946) (Subject)

    2/6/26 8:05:44 PM ET
    $ARLO
    Consumer Electronics/Appliances
    Consumer Staples

    Universal Safety Products Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - UNIVERSAL SAFETY PRODUCTS, INC. (0000102109) (Filer)

    2/6/26 4:30:57 PM ET
    $UUU
    Electronic Components
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Array Technologies Inc.

    SCHEDULE 13G/A - Array Technologies, Inc. (0001820721) (Subject)

    2/6/26 12:08:56 PM ET
    $ARRY
    Miscellaneous manufacturing industries
    Consumer Discretionary

    $ADV
    $AGEN
    $AKA
    $ANF
    Leadership Updates

    Live Leadership Updates

    View All

    Arlo Technologies Announces Inducement Awards Under NYSE Rule 303A.08

    SAN JOSE, Calif., Feb. 4, 2026 /PRNewswire/ -- Arlo Technologies, Inc. (NYSE:ARLO), a leading smart home security brand, today announced that it had made equity grants to new employees under its 2018 Equity Incentive Plan in accordance with NYSE Rule 303A.08. On February 4, 2026, Arlo's Compensation and Human Capital Committee granted restricted stock units, or RSUs, to three new non-executive employees covering an aggregate of 17,380 shares of the Company's common stock as an inducement for such employees to join the Company. The RSUs vest annually in four equal annual instal

    2/4/26 6:19:00 PM ET
    $ARLO
    Consumer Electronics/Appliances
    Consumer Staples

    Rigel Appoints Michael P. Miller to the Board of Directors

    SOUTH SAN FRANCISCO, Calif., Feb. 3, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) today announced that it has appointed Michael P. Miller to its Board of Directors. Mr. Miller has more than four decades of experience in commercial and leadership roles in the biotechnology and pharmaceutical industries. "Mike has a strong track record of commercial excellence, and we're delighted to have him join our Board," said Raul Rodriguez, Rigel's president and CEO. "His extensive expertise in commercial execution and leadership will provide valuable insights as we execute on our transformational strategic plan, particularly our objectives of growing our current portfolio of medicines

    2/3/26 8:05:00 AM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development

    SAN DIEGO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ:CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced a leadership transition designed to support the Company's next phase of growth and advancement toward late-stage development and key clinical and corporate milestones. Mani Mohindru, PhD, a member of Cardiff Oncology's Board of Directors since 2021 and a seasoned biotech executive, has been appointed interim Chief Executive Officer, effective immediately. Mark Erlander, PhD, Chief Executive Officer, and James Levine, Chief Financial Officer, have stepped down from their res

    1/27/26 7:00:00 AM ET
    $CRDF
    $CTMX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ADV
    $AGEN
    $AKA
    $ANF
    Financials

    Live finance-specific insights

    View All

    TeraWulf Schedules Conference Call for Fourth Quarter 2025 Financial Results

    EASTON, Md., Feb. 06, 2026 (GLOBE NEWSWIRE) -- TeraWulf Inc. (NASDAQ:WULF) ("TeraWulf" or the "Company"), a leading owner and operator of vertically integrated digital infrastructure, today announced that it will host its earnings conference call and webcast for the fourth quarter ended December 31, 2025 on Thursday, February 26, 2026 at 4:30 p.m. Eastern Time. A press release detailing the Company's financial results will be issued prior to the call on the same day. Conference Call Information To participate in this event, please log on or dial in approximately five minutes before the scheduled start time. Date: February 26, 2026Time: 4:30 p.m. ETAccess ID: 13758665Webcast: https://vi

    2/6/26 9:28:54 AM ET
    $WULF
    EDP Services
    Technology

    Abercrombie & Fitch Co. to Report Fourth Quarter and Full Year 2025 Results on March 4, 2026

    NEW ALBANY, Ohio, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Abercrombie & Fitch Co. (NYSE:ANF) will host its quarterly earnings conference call for all interested parties on Wednesday, March 4, 2026, at 8:30 a.m. ET. A press release detailing the company's fourth quarter and full year results is expected to be issued shortly after 7:30 a.m. ET. In addition, a presentation of the fourth quarter and full year results will be available on the company's website at approximately 7:30 a.m. ET. Conference Call:To access the conference call by phone, participants will need to register to obtain a dial-in phone number and an access code. Register for the call using this link.  Webcast:To listen to a live w

    2/6/26 8:00:00 AM ET
    $ANF
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    SASOL LIMITED: TRADING STATEMENT FOR THE SIX MONTHS ENDED 31 DECEMBER 2025

    JOHANNESBURG, Feb. 5, 2026 /PRNewswire/ -- In terms of paragraph 3.4(b)(i) of the Listing Requirements of the JSE Limited (JSE) stakeholders are advised that, for the six months ended 31 December 2025: Earnings per share (EPS) is expected to be between R0,10 and R0,80 per share (prior period EPS of R7,22), a decrease of 89% to 99% compared to the prior period;Headline earnings per share (HEPS) is expected to be between R8,50 and R10,00 per share (prior period HEPS of R14,13), a decrease of 29% to 40% compared to the prior period; andAdjusted earnings before interest, tax, depreciation and amortisation (adjusted EBITDA*) is expected to be between R19 billion and R23 billion (prior period adj

    2/5/26 8:14:00 AM ET
    $SSL
    Oil & Gas Production
    Energy

    $ADV
    $AGEN
    $AKA
    $ANF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/16/24 9:09:02 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/12/24 4:17:36 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/10/24 4:15:32 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology